Table of Contents

Articles

• You have access

  DETECTION OF CARBOXYLIC ACIDS AND INHIBITION OF HIPPURIC ACID FORMATION IN RATS TREATED WITH 3-BUTENE-1,2-DIOL, A MAJOR METABOLITE OF 1,3-BUTADIENE

  Christopher L. Sprague and Adnan A. Elfarra

  Drug Metabolism and Disposition August 2003, 31 (8) 986-992; DOI: https://doi.org/10.1124/dmd.31.8.986
• You have access

  GLUCURONIDATION AND EXCRETION OF NONYLPHENOL IN PERFUSED RAT LIVER

  Tomo Daidoji, Hiroki Inoue, Seiyu Kato and Hiroshi Yokota

  Drug Metabolism and Disposition August 2003, 31 (8) 993-998; DOI: https://doi.org/10.1124/dmd.31.8.993
• You have access

  SUBSTITUENT EFFECT ON THE REDUCTIVE N-DEARYLATION OF 3-(INDOL-1-YL)-1,2-BENZISOXAZOLES BY RAT LIVER MICROSOMES

  Richard A. Tschirret-Guth and Harold B. Wood

  Drug Metabolism and Disposition August 2003, 31 (8) 999-1004; DOI: https://doi.org/10.1124/dmd.31.8.999
• You have access

  IN VITRO DRUG INTERACTIONS OF CYTOCHROME P450: AN EVALUATION OF FLUOROGENIC TO CONVENTIONAL SUBSTRATES

  Lawrence H. Cohen, Michael J. Remley, David Raunig and Alfin D. N. Vaz

  Drug Metabolism and Disposition August 2003, 31 (8) 1005-1015; DOI: https://doi.org/10.1124/dmd.31.8.1005
• You have access

  MOLECULAR CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF RAT MULTIDRUG RESISTANCE PROTEIN 1 (MRP1)

  Kenichi Nunoya, Caroline E. Grant, Dawei Zhang, Susan P. C. Cole and Roger G. Deeley

  Drug Metabolism and Disposition August 2003, 31 (8) 1016-1026; DOI: https://doi.org/10.1124/dmd.31.8.1016
• You have access

  GLUCURONIDATION OF HMR1098 IN HUMAN MICROSOMES: EVIDENCE FOR THE INVOLVEMENT OF UGT1A1 IN THE FORMATION OF S-GLUCURONIDES

  Brian T. Ethell, Jens Riedel, Heinrich Englert, Herbert Jantz, Raymond Oekonomopulos and Brian Burchell

  Drug Metabolism and Disposition August 2003, 31 (8) 1027-1034; DOI: https://doi.org/10.1124/dmd.31.8.1027
• You have access

  COMPARISON OF PRIMARY HUMAN HEPATOCYTES AND HEPATOMA CELL LINE HEPG2 WITH REGARD TO THEIR BIOTRANSFORMATION PROPERTIES

  Stefan Wilkening, Frank Stahl and Augustinus Bader

  Drug Metabolism and Disposition August 2003, 31 (8) 1035-1042; DOI: https://doi.org/10.1124/dmd.31.8.1035
• You have access

  K_IIV, AN IN VIVO PARAMETER FOR PREDICTING THE MAGNITUDE OF A DRUG INTERACTION ARISING FROM COMPETITIVE ENZYME INHIBITION

  John M. Neal, Kent L. Kunze, René H. Levy, Robert A. O'Reilly and William F. Trager

  Drug Metabolism and Disposition August 2003, 31 (8) 1043-1048; DOI: https://doi.org/10.1124/dmd.31.8.1043
• You have access

  ROLES OF HUMAN CYP2A6 AND 2B6 AND RAT CYP2C11 AND 2B1 IN THE 10-HYDROXYLATION OF (–)-VERBENONE BY LIVER MICROSOMES

  Mitsuo Miyazawa, Atsushi Sugie and Tsutomu Shimada

  Drug Metabolism and Disposition August 2003, 31 (8) 1049-1053; DOI: https://doi.org/10.1124/dmd.31.8.1049
• You have access

  A TRANSGENIC MOUSE MODEL WITH A LUCIFERASE REPORTER FOR STUDYING IN VIVO TRANSCRIPTIONAL REGULATION OF THE HUMAN CYP3A4 GENE

  Weisheng Zhang, Anthony F. Purchio, Kevin Chen, Jianming Wu, Li Lu, Richard Coffee, Pamela R. Contag and David B. West

  Drug Metabolism and Disposition August 2003, 31 (8) 1054-1064; DOI: https://doi.org/10.1124/dmd.31.8.1054
• You have access

  DEGRADATION OF GINSENOSIDES IN HUMANS AFTER ORAL ADMINISTRATION

  Mona Abdel Tawab, Ute Bahr, Michael Karas, Mario Wurglics and Manfred Schubert-Zsilavecz

  Drug Metabolism and Disposition August 2003, 31 (8) 1065-1071; DOI: https://doi.org/10.1124/dmd.31.8.1065